The Expanding Role of Mass Spectrometry in Metabolite Profiling and Characterization
- 26 October 2005
- journal article
- review article
- Published by Wiley in ChemBioChem
- Vol. 6 (11) , 1941-1951
- https://doi.org/10.1002/cbic.200500151
Abstract
Mass spectrometry has a strong history in drug‐metabolite analysis and has recently emerged as the foremost technology in endogenous metabolite research. The advantages of mass spectrometry include a wide dynamic range, the ability to observe a diverse number of molecular species, and reproducible quantitative analysis. These attributes are important in addressing the issue of metabolite profiling, as the dynamic range easily exceeds nine orders of magnitude in biofluids, and the diversity of species ranges from simple amino acids to lipids to complex carbohydrates. The goals of the application of mass spectrometry range from basic biochemistry to clinical biomarker discovery with challenges in generating a comprehensive profile, data analysis, and structurally characterizing physiologically important metabolites. The precedent for this work has already been set in neonatal screening, as blood samples from millions of neonates are tested routinely by mass spectrometry as a diagnostic tool for inborn errors of metabolism. In this review, we will discuss the background from which contemporary metabolite research emerged, the techniques involved in this exciting area, and the current and future applications of this field.Keywords
This publication has 103 references indexed in Scilit:
- Strategies for characterization of drug metabolites using liquid chromatography–tandem mass spectrometry in conjunction with chemical derivatization and on-line H/D exchange approachesJournal of Pharmaceutical and Biomedical Analysis, 2005
- Threshold extraction in metabolite concentration dataBioinformatics, 2004
- Pharmacodynamic population analysis in chronic renal failure using artificial neural networks—a comparative studyNeural Networks, 2003
- Mass Spectrometry-based Diagnostics: The Upcoming Revolution in Disease Detection Has Already ArrivedClinical Chemistry, 2003
- Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression DataJournal of the American Statistical Association, 2002
- Metabonomics: a platform for studying drug toxicity and gene functionNature Reviews Drug Discovery, 2002
- Determination of 4‐hydroxytamoxifen in mouse plasma in the pg/mL range by gradient capillary liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2001
- 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic dataXenobiotica, 1999
- Chemical Characterization of a Family of Brain Lipids That Induce SleepScience, 1995
- Mass spectral properties of volatile derivatives of thyronine (To) and use of these in the study of thyronine excretion in Eu-, Hyper- and hypothroidismJournal of Mass Spectrometry, 1984